Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health claims

This article was originally published in The Tan Sheet

Executive Summary

FDA is expecting "imminent publication" of the folic acid proposals as well as a document "reopening" the comment period for "health claim topics which were not approved in the January publication" of the Nutrition Labeling & Education Act regulations, FDA's Office of Special Nutritionals Director Elizabeth Yetley, PhD, tells the Council for Responsible Nutrition annual conference on Sept. 23. The health claim topics include: zinc and immune function in the elderly; folic acid and neural tube defects; omega-3 fatty acids and coronary heart disease; antioxidants and cancer; and dietary fiber and cancer/cardiovascular disease. Yetley also said that a public conference to discuss antioxidant health claims is slated for Nov. 1-3 in Washington, D.C. ("The Tan Sheet" Sept. 20, In Brief), and that a similar conference on dietary fiber and cancer/heart disease will be held "sometime after the first of the calendar year".
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081947

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel